Spero Therapeutics, Inc.SPRONASDAQ
LOADING
|||
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | -329.04% |
| Q2 2025 | 87.88% |
| Q1 2025 | 35.90% |
| Q4 2024 | -21.88% |
| Q3 2024 | 3.03% |
| Q2 2024 | -37.50% |
| Q1 2024 | -124.74% |
| Q4 2023 | 1695.39% |
| Q3 2023 | 73.57% |
| Q2 2023 | 0.00% |
| Q1 2023 | -141.82% |
| Q4 2022 | 266.67% |
| Q3 2022 | 62.07% |
| Q2 2022 | 20.18% |
| Q1 2022 | -19.78% |
| Q4 2021 | -30.00% |
| Q3 2021 | -11.11% |
| Q2 2021 | 4.55% |
| Q1 2021 | 2.94% |
| Q4 2020 | 20.93% |
| Q3 2020 | -1.18% |
| Q2 2020 | 28.57% |
| Q1 2020 | 9.85% |
| Q4 2019 | -38.95% |
| Q3 2019 | -28.38% |
| Q2 2019 | -155.17% |
| Q1 2019 | 51.67% |
| Q4 2018 | 0.00% |
| Q3 2018 | 13.04% |
| Q2 2018 | 6.76% |
| Q1 2018 | 53.46% |
| Q4 2017 | -117.81% |
| Q3 2017 | 47.48% |
| Q2 2017 | -56.18% |
| Q1 2017 | 18.35% |
| Q4 2016 | -13.54% |
| Q3 2016 | 0.00% |